Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interference and Safety of Concomitant Administration of Measles-rubella and Rotavirus Vaccines at 9 Months of Age in Rural Bangladesh

NCT01700621 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT01700621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interference and Safety of Concomitant Administration of Measles-rubella and Rotavirus Vaccines at 9 Months of Age in Rural Bangladesh
Lead sponsor
PATH
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
September 30, 2013
Enrollment
482 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

measles antibody seroconversion, rotavirus geometric mean titer (gmt), rotavirus immunoglobulin a (iga) seropositivity, rubella antibody seroconversion